Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002

BACKGROUND: A dramatic increase in the incidence of the diffuse form of gastric adenocarcinomas and particularly signet ring cell carcinomas has been observed in Western countries. Evidence is accruing that signet ring cell carcinomas may have inherent chemo resistance leaving many clinicians unsure...

Descripción completa

Detalles Bibliográficos
Autores principales: Piessen, Guillaume, Messager, Mathieu, Le Malicot, Karine, Robb, William B, Di Fiore, Frédéric, Guilbert, Marie, Moreau, Marie, Christophe, Véronique, Adenis, Antoine, Mariette, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694478/
https://www.ncbi.nlm.nih.gov/pubmed/23758655
http://dx.doi.org/10.1186/1471-2407-13-281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694478/
https://www.ncbi.nlm.nih.gov/pubmed/23758655
http://dx.doi.org/10.1186/1471-2407-13-281

Ejemplares similares